Connection

Peter Verhamme to Anticoagulants

Back to Details
This is a "connection" page, showing publications Peter Verhamme has written about Anticoagulants.
Peter Verhamme
Connection Strength
0.584
Anticoagulants
  1. The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: executive summary. Europace. 2018 08 01; 20(8):1231-1242.
    View in: PubMed
    Score: 0.041
  2. Clinical Impact of Bleeding in Cancer-Associated Venous Thromboembolism: Results from the Hokusai VTE Cancer Study. Thromb Haemost. 2018 Aug; 118(8):1439-1449.
    View in: PubMed
    Score: 0.041
  3. Management of major bleeding and outcomes in patients treated with direct oral anticoagulants: results from the START-Event registry. Intern Emerg Med. 2018 Oct; 13(7):1051-1058.
    View in: PubMed
    Score: 0.040
  4. The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. Eur Heart J. 2018 04 21; 39(16):1330-1393.
    View in: PubMed
    Score: 0.040
  5. Targeting Coagulase Activity in Staphylococcus aureus Bacteraemia: A Randomized Controlled Single-Centre Trial of Staphylothrombin Inhibition. Thromb Haemost. 2018 05; 118(5):818-829.
    View in: PubMed
    Score: 0.040
  6. Acute non-cirrhotic portal vein thrombosis : review. Acta Gastroenterol Belg. 2018 Apr-Jun; 81(2):318-322.
    View in: PubMed
    Score: 0.040
  7. The adsorption of dabigatran is as efficient as addition of idarucizumab to neutralize the drug in routine coagulation assays. Int J Lab Hematol. 2018 Aug; 40(4):442-447.
    View in: PubMed
    Score: 0.040
  8. European guidelines on perioperative venous thromboembolism prophylaxis: Mechanical prophylaxis. Eur J Anaesthesiol. 2018 Feb; 35(2):112-115.
    View in: PubMed
    Score: 0.039
  9. Impact of Thrombus Sidedness on Presentation and Outcomes of Patients with Proximal Lower Extremity Deep Vein Thrombosis. Semin Thromb Hemost. 2018 Jun; 44(4):341-347.
    View in: PubMed
    Score: 0.039
  10. Laboratory testing in patients treated with direct oral anticoagulants: a practical guide for clinicians. J Thromb Haemost. 2018 02; 16(2):209-219.
    View in: PubMed
    Score: 0.039
  11. Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism. N Engl J Med. 2018 Feb 15; 378(7):615-624.
    View in: PubMed
    Score: 0.039
  12. Outpatient Management in Patients with Venous Thromboembolism with Edoxaban: A Post Hoc Analysis of the Hokusai-VTE Study. Thromb Haemost. 2017 12; 117(12):2406-2414.
    View in: PubMed
    Score: 0.039
  13. Anticoagulation of pregnant women with mechanical heart valves: protecting mother or child? Eur Heart J. 2017 05 14; 38(19):1517-1519.
    View in: PubMed
    Score: 0.037
  14. Abnormal uterine bleeding in VTE patients treated with rivaroxaban compared to vitamin K antagonists. Thromb Res. 2015 Oct; 136(4):749-53.
    View in: PubMed
    Score: 0.033
  15. Management of Patients with Asymptomatic and Symptomatic Carotid Artery Disease: Update on Anti-Thrombotic Therapy. Thromb Haemost. 2019 Apr; 119(4):576-585.
    View in: PubMed
    Score: 0.010
  16. Lemierre Syndrome: Clinical Update and Protocol for a Systematic Review and Individual Patient Data Meta-analysis. Hamostaseologie. 2019 Feb; 39(1):76-86.
    View in: PubMed
    Score: 0.010
  17. European guidelines on perioperative venous thromboembolism prophylaxis: Intensive care. Eur J Anaesthesiol. 2018 Feb; 35(2):142-146.
    View in: PubMed
    Score: 0.010
  18. Idarucizumab for Dabigatran Reversal - Full Cohort Analysis. N Engl J Med. 2017 08 03; 377(5):431-441.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.